1.Clinical Observation on Effect of Nicorandil in Angina Pectoris.
Kyung Ho LEE ; Won Tae CHUNG ; Jang Geun PARK ; Gyo Ik SOHN ; Woung Woo SHIN ; Yeong Kee SHIN
Korean Circulation Journal 1987;17(3):519-525
We evaluated the clinical effects of Nicorandil in 27 patients (17 male and 10 female) with ischemic heart disease (17 patients of stable effort angina, 3 patients of unstable effort angina, 6 patients of spontaneous angina, 1 patient of variant angina) in terms of the effect on the anginal pain, electrocardiographic changes and side effects. The results obtained were as follows; 1. The pulse rate was not changed by the drug administration and blood pressure were decreased slightly by Nicorandil in a daily dose of 15 mg divided into 3 dose, but these decrease were not significant in statistical meaning. 2. Improvement in EKG changes was observed in 9 patients (69%) among the 13 patients who showed abnormal EKG initially. 3. Anti-anginal effect of nicorandil were excellent in 14 patients, good in 8 patients, fair in 3 patients and so the rate of global improvement was 82%. 4. Nicorandil had side effects in 7 patients, headache (4 patients), palpitation, ocular pain, edema, but these were transitory and tolerable except of one case who could not be continued because of severe headache.
Angina Pectoris*
;
Blood Pressure
;
Edema
;
Electrocardiography
;
Headache
;
Heart Rate
;
Humans
;
Male
;
Myocardial Ischemia
;
Nicorandil*
2.Evaluation of the Mitral Valve Resistance as a Hemodynamic Parameter in Mitral Stenosis.
Woo Seog KO ; Jun Hong KIM ; Bu Woung KIM ; Seong Yoon HWANG ; Taek Jong HONG ; Young Woo SHIN ; Yeong Kee SHIN
Korean Circulation Journal 1995;25(2):451-458
BACKGROUND: Mitral stenosis is charcterized by decrease in mitral valve area anatomically and increase in transmitral pressure gradient hemodynamically. And these changes have been used to quantify the severity of mitral stenosis clinically. To evaluate the clinical usefulness of mitral valve resistance as a hemodynamic parameter in patients with mitral stenosis, we compared the mitral valve resistance to the clinical status of the patient with mitral stenosis, the other hemodynamic parameters and static parameter. METHODS: We analyzed and reviewed the data obtained from the consecutive 27 patients with mitral stenosis(7 male, 20 female : mean age 38+/-9 years) who had been underwent percutaneous mitral valvuloplasty(PMV). RESULTS: Befor PMV, the mitral valve resistance was significantly correlated with exercise capacity on treadmill test(r=-0.37, p<0.05), mitral valve area(r=-0.72, p<0.01), transmitral mean pressure gradient(r=0.83, p<0.01),not with cardiac output, mixed venous oxygen saturation. After PMV, the mitral valve resistance was significantly correlated with mitral valve area (r=-0.72, p<0.01), transmitral mean pressure gradient(r=0.90, p<0.01).According to the results summerizing and comparing the values of before and after percutaneous mitral valvuloplasty, the mitral valve resistance had good relationship with preexisting paramerters of severity such as mitral valve area(r=-0.82, p<0.01), transmitral mean pressure gradient (r=0.92, p<0.01). CONCLUSION: This results indicate that the mitral valve resistance is a useful hemodynamic parameter in patients with mitral valve stenosis and reflects the exercise capacity during the treadmill test which was the objective parameter of practical and clinical status of the patient well than the other hemodynamic parameters in case of remarkably reduced transmitral valve blood flow due to severe mitral valve stenosis, because the degree of change in the mitral valve resistance in relagion to the degree of change in transmitral valve blood flow is relatively more constant than the other hemodynamic parameters.
Cardiac Output
;
Exercise Test
;
Female
;
Hemodynamics*
;
Humans
;
Male
;
Mitral Valve Stenosis*
;
Mitral Valve*
;
Oxygen
3.RET/PTC and CK19 Expression in Papillary Thyroid Carcinoma and Its Clinicopathologic Correlation.
Eunah SHIN ; Woung Youn CHUNG ; Woo Ick YANG ; Cheong Soo PARK ; Soon Won HONG
Journal of Korean Medical Science 2005;20(1):98-104
Recently, the rearrangement of RET proto-oncogene has been reported to be the most common genetic change in papillary thyroid carcinoma (PTC). However, its prevalence has been reported variably and its relation to clinical outcome has been controversial. The characteristic nuclear features of PTC usually render the diagnosis, but problem arises with equivocal cytologic features that are present focally. Although there remains some controversy, CK19 has been reported to be a useful ancillary tool for diagnosis of PTC. To evaluate the expression rate of RET/PTC rearrangement and CK19 in PTCs in a Korean population, we studied 115 papillary thyroid carcinomas in 3 mm-core tissue microarray based immunohistochemical analysis. The prevalence of Ret protein expression was 62.6% and the CK19 immunoreactivity was 80.9%. There was no statistically significant asso-ciation between the Ret positivity and CK19 immunoreactivity, although the percent agreement of the two was relatively high. The clinicopathological variables did not correlate with the expression of Ret. In conclusion, the prevalence of Ret protein expression and its clinicopathological implications in a Korean population are not much different from those reported in previous studies. However, its detection via immunohistochemistry can be a useful diagnostic tool for diagnosing papillary thyroid carcinoma in conjunction with CK19.
Adenocarcinoma, Papillary/*metabolism
;
Adult
;
Carcinoma/pathology
;
Cell Line, Tumor
;
Cytoplasm/metabolism
;
Female
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Immunohistochemistry
;
Keratin/*biosynthesis
;
Korea
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Oligonucleotide Array Sequence Analysis
;
Oncogene Proteins/*biosynthesis
;
Receptor Protein-Tyrosine Kinases/*biosynthesis
;
Thyroid Neoplasms/*metabolism/pathology
4.Plasma Glucose, Insulin and C-Peptide in Essential Hypertension.
Bu Woung KIM ; Seong Yoon HWANG ; Woo Seog KO ; Jun Hong KIM ; Sa Woong KIM ; Joon Hoon JEONG ; Hyun Myung OAH ; Yong Ki KIM ; Yeong Kee SHIN
Korean Circulation Journal 1995;25(5):975-986
BACKGROUND: High blood pressure is prevalent in obesity and diabetes, especially noninsulin dependent diabetes mellitus, and both conditions are insulin resistant state. METHOD: To test whether resistance to insulin-stimulated glucose uptake and hyperinsulinemia are involved in the pochogenesis of hypertension, author measured glucose, insulin and C-Peptide reponse after oral glucose loading in 52 cases of essential hypertension and 62 cases of normal controls who had been admitted to the ward of internal medicine, Pusan National University Hospita. RESULTS: Basal plasma glucose, insulin and C-Peptide levels in control subjects were 92.1+/-36.8mg/dl, 8.7+/-5.5microu/ml and 2.2+/-1.8ng/ml and in hypertensive subjects were 95.7+/-32.6mg/dl, 12.2+/-5.3microu/ml and 2.9+/-1.6ng/ml. The basal insulin level was markedly higher than tat of control subjets (p<0.05). The basal glucose and C-Peptide levels in hypertensive patioents were higher than controls but statistically not significant. Plasma glucose levels in time course after glucose load in hypertensive patients showed significantly higher levels in 60,90minutes than controls. Plasma insulin levels in hypertensives in 90 minutes were significantly higher. The C-Peptide levels in hypertensives showed significantly higher in each times 30,60,90,120 minutes than controls. In hypertensive patients, body weight, blood pressure levels and duration of hypertension were not significantly correlated with responses of glucose, insalin and c-peptioce. Hypertensive patients aboce the age of 50 showed significantly higher glucose levels in 60,90,120 minutes than under age of 50. CONCLUSION: These results indicate some tendency of disturbed glucose turnover or insulin-resistant state in essential hypertension. This metabolic disturbance in essential hypertension should be considered in the management of hypertensive patients.
Blood Glucose*
;
Blood Pressure
;
Body Weight
;
Busan
;
C-Peptide*
;
Diabetes Mellitus
;
Glucose
;
Humans
;
Hyperinsulinism
;
Hypertension*
;
Insulin Resistance
;
Insulin*
;
Internal Medicine
;
Obesity
;
Plasma*